CorMedix (CRMD) Posts 157% Revenue Growth and $26M in Profit but There’s an Acquisition Twist
Healthcare investing has a weakness for the next miracle drug. Understandable, although the less glamorous businesses deserve a…
Top 6 Small-Cap Healthcare Stocks to Buy Right Now
Healthcare investing has a weakness for the next miracle drug. Understandable, although the less glamorous businesses deserve a…
Top 5 Small-Cap Medical Stocks to Buy Before August 2026 Ends
In this article, we break down the Top 5 Small-Cap Medical Stocks to Buy Before August 2026 Ends.…
Here’s What Makes CorMedix (CRMD) a Smart Long-Term Buy
In this article, we break down the Top 5 Microcap Biotech Stocks That Could Multiply Your Money Fast.…
Top 5 Microcap Biotech Stocks That Could Multiply Your Money Fast
In this article, we break down the Top 5 Microcap Biotech Stocks That Could Multiply Your Money Fast.…
CorMedix (CRMD) Surges After Posting $108.6M Net Income in Q3 2025
CorMedix Inc. (NASDAQ:CRMD) is a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, dedicated to developing and commercializing…
CorMedix (CRMD) Revenue to Hit $350M After Melinta Buyout
CorMedix Inc. (NASDAQ: CRMD) is a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, dedicated to the development…
CorMedix (CRMD) Just Posted Its 1st Profit—Is This Biotech Rocket About to Launch?
CorMedix Inc. (NASDAQ: CRMD) is a commercial-stage biopharmaceutical company that has reached a rare inflection point for small-cap…